

- Elizabeth holmes theranos how to#
- Elizabeth holmes theranos trial#
- Elizabeth holmes theranos series#
Elizabeth holmes theranos series#
įollowing Murdoch’s investment, Theranos raised a $9.1 million Series B funding round led by ATA Ventures and a $28.5 million Series C, both in 2006.
Elizabeth holmes theranos trial#
The pair have both pleaded not guilty to the charges.īalwani’s trial is expected to begin next year. Federal prosecutors allege that the pair defrauded investors by lying about the accuracy of Theranos’ tests and technology, and defrauded patients by providing tests that weren’t as accurate as advertised. Holmes and Balwani each face two counts of conspiracy to commit wire fraud and 10 counts of wire fraud. Without denying or admitting to the charges, Holmes separately settled with the SEC, agreeing to pay a $500,000 penalty. Palo Alto-based Theranos was officially dissolved in 2018. Instead, as jury selection continues for Holmes’ trial, we’re taking a look at the investment dollars the company netted, the high-profile partnerships it formed, and the big names that backed and advised Theranos before the company went from a Silicon Valley star to a cautionary tale.īefore Holmes and her ex-boyfriend, Theranos’ former president and COO Ramesh “Sunny” Balwani, were indicted, the company was the subject of civil and criminal investigations, and settled with the U.S. There are already plenty of books, movies and podcasts about the Theranos saga, so we’re not going to rehash too much of the drama that led to the company’s downfall. Now, founder Elizabeth Holmes is on trial. The company claimed its technology could run blood tests with just a prick of a finger, but it was later revealed that Theranos used traditional blood testing machines for the majority of its tests, and that its own technology could produce inaccurate test results.

Theranos was once a Silicon Valley golden child, expanding rapidly, partnering with a major pharmacy, and raising over a billion dollars in funding.īut all of that came crashing down after a series of explosive reports, starting in 2015, by The Wall Street Journal reporter John Carreyrou, who called into question the efficacy of Theranos’ technology.
Elizabeth holmes theranos how to#
Freelance Writers: How To Pitch Crunchbase News.
